These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 10190894
1. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP. J Exp Med; 1999 Apr 05; 189(7):1033-42. PubMed ID: 10190894 [Abstract] [Full Text] [Related]
2. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy. Steinman L. J Exp Med; 1999 Apr 05; 189(7):1021-4. PubMed ID: 10190892 [No Abstract] [Full Text] [Related]
3. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. Yu M, Johnson JM, Tuohy VK. J Exp Med; 1996 Apr 01; 183(4):1777-88. PubMed ID: 8666934 [Abstract] [Full Text] [Related]
4. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. Yu M, Johnson JM, Tuohy VK. J Neurosci Res; 1996 Aug 15; 45(4):463-70. PubMed ID: 8872907 [Abstract] [Full Text] [Related]
5. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel PR. J Autoimmun; 1999 Aug 15; 13(1):11-20. PubMed ID: 10441163 [Abstract] [Full Text] [Related]
6. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. J Exp Med; 1995 Jul 01; 182(1):75-85. PubMed ID: 7540658 [Abstract] [Full Text] [Related]
7. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy VK, Yu M, Yin L, Kawczak JA, Johnson JM, Mathisen PM, Weinstock-Guttman B, Kinkel RP. Immunol Rev; 1998 Aug 01; 164():93-100. PubMed ID: 9795767 [Abstract] [Full Text] [Related]
8. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K, Chandler P, Altmann DM. Eur J Immunol; 1997 Nov 01; 27(11):2927-34. PubMed ID: 9394820 [Abstract] [Full Text] [Related]
9. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809 [Abstract] [Full Text] [Related]
11. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. Miller SD, Eagar TN. Adv Exp Med Biol; 2001 Jan 15; 490():99-107. PubMed ID: 11505979 [Abstract] [Full Text] [Related]
12. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Slavin A, Ewing C, Liu J, Ichikawa M, Slavin J, Bernard CC. Autoimmunity; 1998 Jan 15; 28(2):109-20. PubMed ID: 9771980 [Abstract] [Full Text] [Related]
13. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD. J Clin Invest; 1999 Sep 15; 104(5):599-610. PubMed ID: 10487774 [Abstract] [Full Text] [Related]
14. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response. Bischof F, Bins A, Dürr M, Zevering Y, Melms A, Kruisbeek AM. J Immunol; 2004 Jul 01; 173(1):600-6. PubMed ID: 15210822 [Abstract] [Full Text] [Related]
15. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. Tuohy VK, Yu M, Yin L, Mathisen PM, Johnson JM, Kawczak JA. J Neuroimmunol; 2000 Nov 01; 111(1-2):55-63. PubMed ID: 11063821 [Abstract] [Full Text] [Related]
16. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers. Bischof F, Hofmann M, Schumacher TN, Vyth-Dreese FA, Weissert R, Schild H, Kruisbeek AM, Melms A. J Immunol; 2004 Mar 01; 172(5):2878-84. PubMed ID: 14978089 [Abstract] [Full Text] [Related]
17. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats. Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K. Immunology; 2009 Sep 01; 128(1 Suppl):e250-61. PubMed ID: 19175799 [Abstract] [Full Text] [Related]
18. Experimental autoimmune encephalomyelitis in the rat. Mannie M, Swanborg RH, Stepaniak JA. Curr Protoc Immunol; 2009 Apr 01; Chapter 15():15.2.1-15.2.15. PubMed ID: 19347844 [Abstract] [Full Text] [Related]
19. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. J Neuroimmunol; 1992 Jun 01; 38(3):229-40. PubMed ID: 1376328 [Abstract] [Full Text] [Related]
20. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R, Domingues HS, Holz A, Kurschus FC, Wekerle H. J Exp Med; 2009 Jun 08; 206(6):1303-16. PubMed ID: 19487416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]